OpenBilldrug price receipt

NADAC week of 2026-10-14

QUILLICHEW ER 40 MG CHEW TAB

FDA nonproprietary name: methylphenidate hydrochloride

For 30 tablets

Pharmacies pay

$356.16 filed

30 × $11.87202 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$374.07 filed

30 × $12.46884 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.1× estimated

Medicare paid 1.1× what pharmacies pay.

Part D averages every strength and form sold under “Quillichew ER” / “Methylphenidate HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$414.58 estimated

$356.16 + $53.42 (15%) + $5.00 fee per fill = $414.58

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

QUILLICHEW ER 40 MG CHEW TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate hydrochloride, under the trade name “QuilliChew ER”.

FDA gives its dosage form as tablet, chewable, extended release and its route as oral.

The labeler, the company named on the label, is NextWave Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 24478-0076-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $356.16 for 30 tablets (30 × $11.87202 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

59 other products in the NADAC file share the FDA nonproprietary name methylphenidate hydrochloride with QUILLICHEW ER 40 MG CHEW TAB. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

ProductPharmacies pay per unitMedicare per unit
CONCERTA ER 18 MG TABLET
brand · tablet, extended release
$12.32528 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 27 MG TABLET
brand · tablet, extended release
$12.65426 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 36 MG TABLET
brand · tablet, extended release
$13.04275 per EA filed
eff. 2026-09-23
We don’t know yet
CONCERTA ER 54 MG TABLET
brand · tablet, extended release
$14.17967 per EA filed
eff. 2026-09-23
We don’t know yet
JORNAY PM 20 MG CAPSULE
brand · capsule
$15.39302 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 40 MG CAPSULE
brand · capsule
$15.40511 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 60 MG CAPSULE
brand · capsule
$15.40191 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 80 MG CAPSULE
brand · capsule
$15.40151 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
JORNAY PM 100 MG CAPSULE
brand · capsule
$15.39596 per EA filed
eff. 2026-09-23
$15.06416 per EA filed
Part D 2024 average
METHYLIN 5 MG/5 ML SOLUTION
brand · solution
$0.16161 per ML filed
eff. 2026-09-23
We don’t know yet
METHYLIN 10 MG/5 ML SOLUTION
brand · solution
$0.23086 per ML filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 2.5 MG CHEW TB
generic · tablet, chewable
$1.29914 per EA filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 5 MG CHEW TAB
generic · tablet, chewable
$2.00923 per EA filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 10 MG CHEW TAB
generic · tablet, chewable
$2.95383 per EA filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 10 MG TABLET
generic · tablet
$0.15796 per EA filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 10 MG/5 ML SOL
generic · solution
$0.1199 per ML filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE 20 MG TABLET
generic · tablet
$0.20139 per EA filed
eff. 2026-09-23
We don’t know yet
METHYLPHENIDATE CD 40 MG CAP
generic · capsule, extended release
$1.44136 per EA filed
eff. 2026-09-23
$2.4095 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(CD) 40 MG CP
generic · capsule, extended release
$1.44136 per EA filed
eff. 2026-09-23
$2.28413 per EA filed
Part D 2024 average
METHYLPHENIDATE ER(LA) 40 MG CP
generic · capsule, extended release
$1.85373 per EA filed
eff. 2026-09-23
$3.41274 per EA filed
Part D 2024 average
QUILLICHEW ER 20 MG CHEW TAB
brand · tablet, chewable, extended release
$11.90025 per EA filed
eff. 2026-09-23
$12.46884 per EA filed
Part D 2024 average
QUILLICHEW ER 30 MG CHEW TAB
brand · tablet, chewable, extended release
$11.88441 per EA filed
eff. 2026-09-23
$12.46884 per EA filed
Part D 2024 average
QUILLICHEW ER 40 MG CHEW TAB this page
brand · tablet, chewable, extended release
$11.87202 per EA filed
eff. 2026-09-23
$12.46884 per EA filed
Part D 2024 average
RITALIN LA 40 MG CAPSULE
brand · capsule, extended release
$12.72548 per EA filed
eff. 2025-10-22
$12.29982 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $11.87202 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 62 have a higher middle NADAC price and 141 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $374.07 for 30 tablets, at an average of $12.46884 per EA in 2024 (2024-01-01 to 2024-12-31) for “Quillichew ER” and “Methylphenidate HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 644 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for QUILLICHEW ER 40 MG CHEW TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Quillichew ER / Methylphenidate HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.